Search

everythinglearnresearchcommunity

for

Search:↓

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Quercetin boosts melanin production in mouse hair follicles.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Both new minoxidil formulations significantly stimulated hair growth and improved dermal metabolism.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Herbomineral drugs effectively manage chemotherapy-induced diarrhea in oral cavity cancer patients.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Dutasteride may reduce insulin sensitivity and increase body fat.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Minoxidil with tretinoin boosts hair growth most effectively, followed by minoxidil alone, and then ketoconazole.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

The herbal extract promoted faster hair regrowth in mice.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.